Currently, Sonali serves as a Senior Director at VS Health Group responsible for strategic launch planning, commercial value assessments, payer insights and executional excellence.
Sonali has a mix of experiences between the biopharmaceutical industry and consulting. At Genentech, Sonali supported the market access launch strategy for Perjeta® in early breast cancer and Rituxan Hycela™ in follicular lymphoma and chronic lymphocytic leukemia. Additionally, she led the execution of several highly utilized unbranded initiatives including the Oncology Trend Report, Love Your Colon and Genentech Oncology Institute. During her time at Pfizer, she worked cross-portfolio to align pricing strategies with affordability in key emerging markets.
Sonali has many years of strategic consulting experiences including Skysis (now Avalere Health), Guidehouse, The Advisory Board Company (now Optum Health) and IQVIA.
Having a blend of consulting and industry experience makes Sonali a highly unique and effective partner to biopharma leaders. She leverages her strategic mindset and prowess in storytelling in helping clients prioritize, problem-solve and communicate successful business strategies.
Sonali has a Masters degree in International Health Policy from the London School of Economics and Bachelor of Arts in Economics from Mount Holyoke College.